๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis

โœ Scribed by Miller, Michael H; Walsh, Shaun V; Atrih, Abdel; Huang, Jeffrey T-J; Ferguson, Michael A J.; Dillon, John F

Book ID
121814197
Publisher
John Wiley and Sons
Year
2014
Tongue
English
Weight
770 KB
Volume
29
Category
Article
ISSN
0815-9319

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The serum proteome of nonalcoholic fatty
The serum proteome of nonalcoholic fatty liver disease: A multimodal approach to discovery of biomarkers of nonalcoholic steatohepatitis
โœ Miller, Michael H; Walsh, Shaun V; Atrih, Abdel; Huang, Jeffrey T-J; Ferguson, M ๐Ÿ“‚ Article ๐Ÿ“… 2014 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 770 KB

## Abstract ## Background and Aim Nonalcoholic fatty liver disease (NAFLD) is a common condition affecting up to 25% of the developed world. It is a progressive disease, leading in some to the development of liver cirrhosis. Currently, accurate diagnosis and staging of this condition is only possi

Serum proteomics and biomarker discovery
Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease
โœ Lauren N. Bell; Janice L. Theodorakis; Raj Vuppalanchi; Romil Saxena; Kerry G. B ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 361 KB ๐Ÿ‘ 2 views

Nonalcoholic fatty liver disease (NAFLD), ranging from relatively benign simple steatosis to progressive nonalcoholic steatohepatitis (NASH) and fibrosis, is an increasingly common chronic liver disease. Liver biopsy is currently the only reliable tool for staging the subtypes of NAFLD; therefore, n